Condensed Consolidated Statements of Stockholders' Equity (UNAUDITED) - USD ($)	Total		Common Stock	Additional Paid-in Capital	Accumulated Retained Earnings	Accumulated Other Comprehensive Income
Beginning balance, value at Dec. 31, 2020	$ 374,000,000		$ 1,000,000	$ 192,000,000	$ 181,000,000
Beginning balance, shares at Dec. 31, 2020			84,000,000
Net income (loss)	(6,771,415)	[1]			(7,000,000)
Activity related to share-based compensation	2,000,000			2,000,000
Derivative instrument adjustments	0
Ending balance, value at Mar. 31, 2021	369,000,000		$ 1,000,000	194,000,000	174,000,000
Ending balance, shares at Mar. 31, 2021			84,000,000
Beginning balance, value at Dec. 31, 2021	$ 1,988,000,000		$ 1,000,000	1,630,000,000	357,000,000
Beginning balance, shares at Dec. 31, 2021	119,904,001		120,000,000
Net income (loss)	$ 50,768,844	[1]			51,000,000
Activity related to share-based compensation	4,000,000			4,000,000
Derivative instrument adjustments	22,000,000					$ 22,000,000
Ending balance, value at Mar. 31, 2022	$ 2,065,000,000		$ 1,000,000	$ 1,634,000,000	$ 408,000,000	$ 22,000,000
Ending balance, shares at Mar. 31, 2022	120,258,347		120,000,000

[1] Net income (loss) for the three months ended March 31, 2022 and 2021 was $50,768,844 and $(6,771,415), respectively.